A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Veröffentlicht: |
2011
|
| _version_ | 1826292260066557952 |
|---|---|
| author | Leijen, S Soetekouw, P Jeffry Evans, T Nicolson, M Schellens, J Learoyd, M Grinsted, L Zazulina, V Pwint, T Middleton, M |
| author_facet | Leijen, S Soetekouw, P Jeffry Evans, T Nicolson, M Schellens, J Learoyd, M Grinsted, L Zazulina, V Pwint, T Middleton, M |
| author_sort | Leijen, S |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T03:11:56Z |
| format | Journal article |
| id | oxford-uuid:b47eda90-468f-4feb-b6db-4ce12d0ee8d5 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T03:11:56Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:b47eda90-468f-4feb-b6db-4ce12d0ee8d52022-03-27T04:26:30ZA phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumorsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b47eda90-468f-4feb-b6db-4ce12d0ee8d5Symplectic Elements at Oxford2011Leijen, SSoetekouw, PJeffry Evans, TNicolson, MSchellens, JLearoyd, MGrinsted, LZazulina, VPwint, TMiddleton, M |
| spellingShingle | Leijen, S Soetekouw, P Jeffry Evans, T Nicolson, M Schellens, J Learoyd, M Grinsted, L Zazulina, V Pwint, T Middleton, M A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors |
| title | A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors |
| title_full | A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors |
| title_fullStr | A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors |
| title_full_unstemmed | A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors |
| title_short | A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors |
| title_sort | phase i open label randomized crossover study to assess the effect of dosing of the mek 1 2 inhibitor selumetinib azd6244 arry 142866 in the presence and absence of food in patients with advanced solid tumors |
| work_keys_str_mv | AT leijens aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT soetekouwp aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT jeffryevanst aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT nicolsonm aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT schellensj aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT learoydm aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT grinstedl aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT zazulinav aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT pwintt aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT middletonm aphaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT leijens phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT soetekouwp phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT jeffryevanst phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT nicolsonm phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT schellensj phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT learoydm phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT grinstedl phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT zazulinav phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT pwintt phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors AT middletonm phaseiopenlabelrandomizedcrossoverstudytoassesstheeffectofdosingofthemek12inhibitorselumetinibazd6244arry142866inthepresenceandabsenceoffoodinpatientswithadvancedsolidtumors |